Abstract: A tablet for oral administration of nutritional indium comprises about 10-50 mg indium sulfate, about 4-20 mg caffeine, about 2-10% by weight cocoa powder, and about 5-10% by weight ethyl cellulose, in combination with about 50-150 ?g of each of zinc oxide, copper (II) oxide, magnesium oxide, potassium iodide, selenium amino acid chelate, chromium amino acid chelate and manganese amino acid chelate.

Abstract: A sublingual dosage form comprises an inert preformed tablet including at least one excipient and at least one wicking agent, with the at least one wicking agent adapted to selectively absorb at least one solvent-borne medicating ingredient from one portion of the inert preformed tablet into another portion of the inert preformed tablet without disintegrating the inert preformed tablet. The inert preformed tablet is medicated with at least one homeopathic ingredient. A person ingests the sublingual dosage form which disintegrates in about 25 seconds to about 120 seconds after placement under a tongue or a buccal area of a mouth of the person. The sublingual dosage form has a friability of less than about 2% and a hardness of about 3 Newtons to about 7 Newtons.

Abstract: A tablet for oral administration of nutritional indium comprises about 10-50 mg indium sulfate, about 4-20 mg caffeine, about 2-10% by weight cocoa powder, and about 5-10% by weight ethyl cellulose, in combination with about 50-150 ?g of each of zinc oxide, copper (II) oxide, magnesium oxide, potassium iodide, selenium amino acid chelate, chromium amino acid chelate and manganese amino acid chelate.